Rolf Gebhardt
Impact in
- Hepatology top 0.2%
- Liver physiology and pathology
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Hepatology 64
- Liver physiology and pathology 63
- Co-authors
- Dieter Mecke (19 shared papers)Bernd Hamprecht (5 shared papers)Frank Gaunitz (34 shared papers)Ralf Dringen (2 shared papers)Sanja Pavlica (4 shared papers)Elke Ueberham (12 shared papers)Sebastian Zellmer (22 shared papers)Jan G. Hengstler (14 shared papers)
- Journals
- Hepatology (12 papers)Planta Medica (9 papers)Cell Biology and Toxicology (8 papers)European Journal of Biochemistry (7 papers)Biochemical and Biophysical Research Communications (7 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Rolf Gebhardt
246 papers receiving 10.2k citations
Peers
Comparison fields: 5 of 156
- Hepatology 2.0k
- Pharmacology 939
- Clinical Biochemistry 587
- Biochemistry 628
- Cancer Research 942
Countries citing papers authored by Rolf Gebhardt
This map shows the geographic impact of Rolf Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Gebhardt more than expected).
Fields of papers citing papers by Rolf Gebhardt
This network shows the impact of papers produced by Rolf Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Gebhardt. The network helps show where Rolf Gebhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Rolf Gebhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 247 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 451 | |
| 2 | 1993 | 439 | |
| 3 | 1983 | 314 | |
| 4 | 2010 | 241 | |
| 5 | 2008 | 228 | |
| 6 | 1997 | 225 | |
| 7 | 2010 | 219 | |
| 8 | 2012 | 207 | |
| 9 | 2014 | 206 | |
| 10 | 2003 | 200 | |
| 11 | 2004 | 164 | |
| 12 | 1996 | 149 | |
| 13 | 2009 | 131 | |
| 14 | 2003 | 128 | |
| 15 | 2016 | 121 | |
| 16 | 1993 | 112 | |
| 17 | 2008 | 105 | |
| 18 | 1993 | 105 | |
| 19 | 1997 | 104 | |
| 20 | Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. | 2002 | 104 |
About Rolf Gebhardt
Rolf Gebhardt is a scholar working on Molecular Biology, Hepatology, Surgery, Oncology and Epidemiology, having authored 247 papers that have together received 10.5k indexed citations. Recurring topics across this work include Liver physiology and pathology (63 papers), Pancreatic function and diabetes (36 papers), Liver Disease Diagnosis and Treatment (30 papers), Drug Transport and Resistance Mechanisms (27 papers), Metabolism and Genetic Disorders (22 papers), Pharmacogenetics and Drug Metabolism (17 papers), Drug-Induced Hepatotoxicity and Protection (13 papers) and Cancer, Hypoxia, and Metabolism (13 papers). The work is most often cited by research in Hepatology (2.0k citations), Pharmacology (939 citations), Clinical Biochemistry (587 citations), Biochemistry (628 citations) and Cancer Research (942 citations). Rolf Gebhardt has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Dieter Mecke, Bernd Hamprecht, Frank Gaunitz, Ralf Dringen, Sanja Pavlica, Elke Ueberham, Sebastian Zellmer, Jan G. Hengstler, Hans-Jörg Burger and Gayane Hrachia Buniatian. Their work appears in journals such as Hepatology, Planta Medica, Cell Biology and Toxicology, European Journal of Biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.